General
THE END OF THE CANADIAN WOMEN’S HEALTH NETWORK?
This is sad sad news. The Canadian Women’s Health Network (CWHN), one of the pillars of the women’s health movement in North America, has announced that it is suspending activities due to a lack of funds […]
OPPORTUNITY FOR PATIENT INPUT – REALLY!
The FDA wants to know how the process for soliciting patients for the “patient focused drug development” meetings is going. That phrase “Patient focused drug development” may ring a bell with you, but if not, […]
REFLECTIONS ON FDA CHANTIX HEARING
In mid October, the FDA convened a special meeting of drug safety and psycho-pharmacology experts to look at whether or not the smoking cessation drug Chantix needed to continue to carry a black box warning. […]
ACT III: NOW THEY’RE PAYING PATIENTS TO GO TO THE FDA
Here’s the third installment of the saga about PR tactics on the “female sexual dysfunction” front as we get closer to the October 27/28 meeting on FSD and Patient-focused drug development. I (L.T.) first wrote […]
NOW THAT THE ICE HAS MELTED, WHAT’S NEXT FOR ALS?
This summer we saw the ultimate game of truth and dare play out over social media with the ALS Ice Bucket Challenge. All over the world ordinary people as well as celebrities, billionaires, professional athletes, police […]
SUBTLETIES OF PLACEBO
Placebo response levels in many drug trials are high, especially with therapeutic areas that rely on patient-reported outcome measures. I (LT) recently read a very thoughtful paper by sexologist Andrea Bradford called “Listening to placebo […]
NOT ALL “PATIENTS” ARE CREATED EQUAL
Recently I (KW) was reminded again that not all “patient” voices are treated equally. All one has to do is look at two Congressional hearings held in Washington DC last month to see how different […]
